At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 209 enrolled
Drug / intervention
Dexamethasone 4mg +1 moredrug
Likely dose
Dexamethasone 4mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dexamethasone for Acute Migraine. A Randomized Dose-comparison Study
In Brief
A Phase 4 clinical trial evaluating Dexamethasone 4mg and Dexamethasone 16mg for Migraine. Completed, enrolled 209 participants across 1 site.
Detailed Summary
Dexamethasone is an evidence-based treatment of acute migraine. This is a randomized comparison of two different doses of dexamethasone for acute migraine. All patients will also be treated with metoclopramide.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartDec 2019
Primary CompletionDec 2022
TodayJul 2026
First PostedOct 2, 2019
Enrollment StartDec 22, 2019
Primary CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 6.8 years ago
Interventions
Dexamethasone 4mgdrug
Dexamethasone 4mg + metoclopramide 10mg, intravenously
Dexamethasone 16mgdrug
Dexamethasone 16mg + metoclopramide 10mg, intravenously